The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,118.00
Bid: 12,120.00
Ask: 12,124.00
Change: 68.00 (0.56%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Thu, 19th Jul 2018 16:19

Friday 20 July 
Acacia MiningHalf Year Results 
BeazleyHalf Year Results 
KCOM GroupTrading Statement 
HomeserveTrading Statement 
RecordTrading Statement 
Monday 23 July 
Ryanair HoldingsQ1 Results
AscentialHalf Year Results 
McColl's Retail GroupHalf Year Results 
TungstenFull Year Results 
Paragon Banking GroupTrading Statement 
MicrogenHalf Year Results 
SthreeHalf Year Results 
JTCTrading Statement 
Tuesday 24 July 
IG Group HoldingsFull Year Results
Drax GroupHalf Year Results 
Fevertree Drinks Half Year Results 
Gresham Technologies Half Year Results 
PZ CussonsFull Year Results
SpectrisHalf Year Results 
Victoria Full Year Results
Centaur Media Half Year Results 
HammersonHalf Year Results 
HuntsworthHalf Year Results 
Unite GroupHalf Year Results 
BritvicTrading Statement 
Wednesday 25 July 
GlaxoSmithKlineHalf Year Results (at 1200 BST)
Vodafone GroupTrading Statement 
Joules GroupFull Year Results 
Wizz AirQ1 Results 
Staffline GroupHalf Year Results 
QuartixHalf Year Results 
IndiviorHalf Year Results 
Burford CapitalHalf Year Results 
Fulham ShoreHalf Year Results 
IDOXHalf Year Results 
IP GroupHalf Year Results 
QinetiQQ1 Results 
Capital & Counties PropertiesHalf Year Results 
InformaHalf Year Results 
Croda InternationalHalf Year Results 
TymanHalf Year Results 
Rathbone BrothersHalf Year Results 
VictrexHalf Year Results 
3i GroupTrading Statement 
AntofagastaQ2 Production
Brewin DolphinTrading Statement 
FresnilloQ2 Production
International Personal FinanceHalf Year Results 
ITVHalf Year Results 
Marston'sTrading Statement 
Metro BankHalf Year Results 
Tullow OilHalf Year Results 
Primary Health PropertiesHalf Year Results 
Thursday 26 July 
Royal Dutch ShellHalf Year Results
SchrodersHalf Year Results
Intu PropertiesHalf Year Results
Howden Joinery Group Half Year Results
EvrazTrading Statement 
Discoverie Group Trading Statement 
Intermediate Capital GroupTrading Statement 
Law Debenture CorpHalf Year Results
SEGRO Half Year Results
Virgin MoneyHalf Year Results
Sage Group Trading Statement 
Compass GroupTrading Statement 
PayPointTrading Statement 
Tarsus Group Half Year Results
Anglo American Half Year Results
AstraZenecaHalf Year Results
BodycoteHalf Year Results
British American TobaccoHalf Year Results
Countrywide Half Year Results
Daily Mail & General Trust ATrading Statement 
DiageoFull Year Results
Impellam GroupHalf Year Results
Inchcape Half Year Results
Jardine Lloyd Thompson GroupHalf Year Results
KAZ Minerals Q2 Production
Sophos Q1 Results
Lancashire HoldingsHalf Year Results
National Express GroupHalf Year Results
RELX Half Year Results
RenishawFull Year Results
Smith & Nephew Half Year Results
Tate & LyleTrading Statement 
Vesuvius Half Year Results
Morgan Advanced Materials Half Year Results
Countryside PropertiesQ3 Results
Franchise BrandsHalf Year Results
CMC MarketsTrading Statement 
Polymetal InternationalQ2 Production
AVEVA GroupTrading Statement 
  

More News
Today 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.